Jon L. Ruckle

Accium BioSciences, Inc. provides ultrasensitive bioanalytical services to the pharmaceutical industry. The company was founded by Ali Arjomand and Michael Chansler in 2004 and is headquartered in Seattle, WA.

Part of Charles River Laboratories International, Inc., Northwest Kinetics, Inc. is a research facility that specializes in Phase 0, I, and II clinical research. The company is based in Tacoma, WA. Northwest Kinetics was acquired by Charles River Laboratories International, Inc. on October 30, 2006 for $29.50 million.

Radiant Research, Inc. is engaged in the provision of clinical research services. It offers services to biopharmaceutical companies by conducting the clinical research protocol and collecting the data necessary to support the drug company's product to the FDA. The firm also provides consulting, regulatory expertise, study concept, protocol design, site selection, project, vendor management, clinical monitoring, medical monitoring, safety review, pharmacovigilance, data management, statistical analysis, reports and presentations. The company was founded in 1997 by Michael K. Lester and is headquartered in Cincinnati, OH.

Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.

Comprehensive Clinical Development, Inc. provides multi therapeutic clinical research services. It engages in conducting early phase studies in Phase I-IIa for large and small biopharmaceutical, biotechnology medical device and consumer companies. The company is headquartered in Phoenix, AZ.

Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ.